News | Women's Health | August 01, 2017

The ACR-accredited breast imaging center installs Fujifilm's ASPIRE Cristalle, the digital FFDM system with DBT

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow

Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, Cali., has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3-D breast imaging technology has been in use at the center since April.

“We are pleased and excited that The Mammography Center has selected Fujifilm’s ASPIRE Cristalle with DBT. It is especially gratifying to know that women in the Monterey area have access to advanced technology such as breast tomosynthesis in their own community,” said Rob Fabrizio, director of strategic marketing, digital radiography and women’s health, Fujifilm Medical Systems U.S.A., Inc. “We look forward to continuing to support The Mammography Center of Monterey in their efforts to educate women and build awareness about the benefits of 3-D mammography with both clinicians and patients.”

In business for 28 years, The Mammography Center of Monterey was seeking to expand its offerings with the latest mammography technology. The facility decided to make an investment in the latest advanced technology versus staying with a traditional 2-D system. After evaluating competitive breast tomosynthesis units—and speaking with both a technologist and a radiologist familiar with the ASPIRE Cristalle—the facility opted for Fujifilm’s ASPIRE Cristalle.

“Radiologists at the center are impressed with the technology and their ability to clearly see details, especially in images of dense breast tissue,” said Mary Lou Catania, RN, founder and president, The Mammography Center of Monterey.

According to Catania, since the center began using ASPIRE Cristalle with DBT, recall rates have dropped and in fact, there have been no patients recalled due to dense breast images.

Catania also stated that the Fujifilm system is easy-to-use, comfortable for patients, and affordable. She credits the company with a smooth installation and excellent training, saying technologists quickly got up to speed on the ASPIRE Cristalle and were able to rapidly get back on track performing a backlog of patient exams.

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.

For more information: www.fujimed.com

 


Related Content

News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
Subscribe Now